Tnf Pharmaceuticals, Stock Current Ratio

TNFA Stock   1.27  0.02  1.55%   
TNF Pharmaceuticals, fundamentals help investors to digest information that contributes to TNF Pharmaceuticals,'s financial success or failures. It also enables traders to predict the movement of TNF Stock. The fundamental analysis module provides a way to measure TNF Pharmaceuticals,'s intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to TNF Pharmaceuticals, stock.
Last ReportedProjected for Next Year
Current Ratio 1.17  1.11 
As of December 25, 2024, Current Ratio is expected to decline to 1.11.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

TNF Pharmaceuticals, Company Current Ratio Analysis

TNF Pharmaceuticals,'s Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.

Current TNF Pharmaceuticals, Current Ratio

    
  1.11  
Most of TNF Pharmaceuticals,'s fundamental indicators, such as Current Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, TNF Pharmaceuticals, is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

TNF Current Ratio Driver Correlations

Understanding the fundamental principles of building solid financial models for TNF Pharmaceuticals, is extremely important. It helps to project a fair market value of TNF Stock properly, considering its historical fundamentals such as Current Ratio. Since TNF Pharmaceuticals,'s main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of TNF Pharmaceuticals,'s historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of TNF Pharmaceuticals,'s interrelated accounts and indicators.
1.0-0.99-0.97-0.89-0.920.650.98-0.57-0.890.651.0-0.27-0.630.980.91
1.0-0.99-0.95-0.87-0.950.650.99-0.64-0.850.650.99-0.21-0.580.960.92
-0.99-0.990.920.830.94-0.73-1.00.640.82-0.73-0.980.150.52-0.95-0.93
-0.97-0.950.920.980.81-0.54-0.910.370.97-0.54-0.980.50.81-0.99-0.84
-0.89-0.870.830.980.7-0.39-0.810.220.99-0.39-0.920.660.91-0.96-0.74
-0.92-0.950.940.810.7-0.63-0.950.830.67-0.63-0.89-0.030.35-0.84-0.88
0.650.65-0.73-0.54-0.39-0.630.76-0.6-0.451.00.660.09-0.140.620.87
0.980.99-1.0-0.91-0.81-0.950.76-0.67-0.810.760.97-0.13-0.50.940.95
-0.57-0.640.640.370.220.83-0.6-0.670.2-0.6-0.52-0.43-0.15-0.44-0.69
-0.89-0.850.820.970.990.67-0.45-0.810.2-0.45-0.920.680.91-0.96-0.76
0.650.65-0.73-0.54-0.39-0.631.00.76-0.6-0.450.660.09-0.140.620.87
1.00.99-0.98-0.98-0.92-0.890.660.97-0.52-0.920.66-0.34-0.680.990.91
-0.27-0.210.150.50.66-0.030.09-0.13-0.430.680.09-0.340.91-0.45-0.18
-0.63-0.580.520.810.910.35-0.14-0.5-0.150.91-0.14-0.680.91-0.76-0.48
0.980.96-0.95-0.99-0.96-0.840.620.94-0.44-0.960.620.99-0.45-0.760.89
0.910.92-0.93-0.84-0.74-0.880.870.95-0.69-0.760.870.91-0.18-0.480.89
Click cells to compare fundamentals

TNF Current Ratio Historical Pattern

Today, most investors in TNF Pharmaceuticals, Stock are looking for potential investment opportunities by analyzing not only static indicators but also various TNF Pharmaceuticals,'s growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current ratio growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of TNF Pharmaceuticals, current ratio as a starting point in their analysis.
   TNF Pharmaceuticals, Current Ratio   
       Timeline  
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
Competition

TNF Price To Sales Ratio

Price To Sales Ratio

0.008258

At present, TNF Pharmaceuticals,'s Price To Sales Ratio is projected to increase slightly based on the last few years of reporting.

TNF Current Ratio Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses TNF Pharmaceuticals,'s direct or indirect competition against its Current Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of TNF Pharmaceuticals, could also be used in its relative valuation, which is a method of valuing TNF Pharmaceuticals, by comparing valuation metrics of similar companies.
TNF Pharmaceuticals, is currently under evaluation in current ratio category among its peers.

TNF Pharmaceuticals, Current Valuation Drivers

We derive many important indicators used in calculating different scores of TNF Pharmaceuticals, from analyzing TNF Pharmaceuticals,'s financial statements. These drivers represent accounts that assess TNF Pharmaceuticals,'s ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of TNF Pharmaceuticals,'s important valuation drivers and their relationship over time.
201920202021202220232024 (projected)
Market Cap19.5K224.5K2.2M2.5M2.9M3.1M
Enterprise Value507.0K(14.3M)1.8M1.9M313.9K329.6K

TNF Fundamentals

About TNF Pharmaceuticals, Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze TNF Pharmaceuticals,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of TNF Pharmaceuticals, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of TNF Pharmaceuticals, based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether TNF Pharmaceuticals, offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of TNF Pharmaceuticals,'s financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Tnf Pharmaceuticals, Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Tnf Pharmaceuticals, Stock:
Check out TNF Pharmaceuticals, Piotroski F Score and TNF Pharmaceuticals, Altman Z Score analysis.
For information on how to trade TNF Stock refer to our How to Trade TNF Stock guide.
You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of TNF Pharmaceuticals,. If investors know TNF will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about TNF Pharmaceuticals, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(10.48)
Return On Assets
(0.32)
Return On Equity
(2.98)
The market value of TNF Pharmaceuticals, is measured differently than its book value, which is the value of TNF that is recorded on the company's balance sheet. Investors also form their own opinion of TNF Pharmaceuticals,'s value that differs from its market value or its book value, called intrinsic value, which is TNF Pharmaceuticals,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because TNF Pharmaceuticals,'s market value can be influenced by many factors that don't directly affect TNF Pharmaceuticals,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between TNF Pharmaceuticals,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if TNF Pharmaceuticals, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, TNF Pharmaceuticals,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.